Skip to main content
Fig. 5 | Diabetology & Metabolic Syndrome

Fig. 5

From: Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis

Fig. 5

The kinetic ratio of AF-AGEs/1,5-AG. The kinetic ratio of AF-AGEs/1,5-AG was 0.454 ± 0.215 U/μg in the control group (N = 30) and 10.4 ± 4.32 U/μg and 9.08 ± 5.41 U/μg in the HD (N = 49) and HDF groups (N = 24), respectively. 1,5-AG, 1,5-anhydroglucitol; AF-AGEs; 1,5-AF-derived advanced glycation end products; HD, hemodialysis; HDF, hemodiafiltration

Back to article page